Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0225 AUD | -2.17% | -15.38% | -37.14% |
02:56am | Chimeric Therapeutics Reopens Enrollment in Phase 1B Cell Therapy Study | MT |
May. 02 | Chimeric Therapeutics Appoints COO; Shares Rise 4% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.14% | 13.16M | |
+7.52% | 113B | |
+11.38% | 106B | |
-12.64% | 22.22B | |
+0.44% | 22.27B | |
-4.18% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+37.41% | 12.52B | |
-23.95% | 8.34B |
- Stock Market
- Equities
- CHM Stock
- News Chimeric Therapeutics Limited
- Chimeric Therapeutics Appoints COO; Shares Rise 4%